128 related articles for article (PubMed ID: 38214480)
21. Pediatric rhabdomyosarcoma in Morocco.
Hessissen L; Kanouni L; Kili A; Nachef MN; El Khorassani M; Benjaafar N; Khattab M; El Gueddari Bel K
Pediatr Blood Cancer; 2010 Jan; 54(1):25-8. PubMed ID: 19746454
[TBL] [Abstract][Full Text] [Related]
22. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
[TBL] [Abstract][Full Text] [Related]
23. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract][Full Text] [Related]
24. Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.
Wang T; Gao X; Yang J; Guo W; Wu Z; Tang L; Cao S; Cai X; Liu T; Jia Q; Xiao J
Clin Neurol Neurosurg; 2020 May; 192():105729. PubMed ID: 32058205
[TBL] [Abstract][Full Text] [Related]
25. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract][Full Text] [Related]
26. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
[TBL] [Abstract][Full Text] [Related]
27. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
[TBL] [Abstract][Full Text] [Related]
28. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.
Skapek SX; Anderson J; Barr FG; Bridge JA; Gastier-Foster JM; Parham DM; Rudzinski ER; Triche T; Hawkins DS
Pediatr Blood Cancer; 2013 Sep; 60(9):1411-7. PubMed ID: 23526739
[TBL] [Abstract][Full Text] [Related]
29. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study.
Heyn R; Beltangady M; Hays D; Lawrence W; Newton W; Crist W; Tefft M; Maurer HM
J Clin Oncol; 1989 Feb; 7(2):200-7. PubMed ID: 2915235
[TBL] [Abstract][Full Text] [Related]
30. Rhabdomyosarcoma of the female genitourinary tract: Primary and relapsed disease in infants and older children. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Matle M; Vokuhl C; Hallmen E; von Kalle T; Münter M; Timmermann B; Bielack SS; Klingebiel T; Koscielniak E; Seitz G;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28889. PubMed ID: 33438323
[TBL] [Abstract][Full Text] [Related]
31. National assessment of lymph node status indicators & predictors in pediatric head and neck rhabdomyosarcomas in the US.
Fei-Zhang DJ; Park AC; Berry JM; Arch RS; Chelius DC; Sheyn AM; Rastatter JC
Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111419. PubMed ID: 36525697
[TBL] [Abstract][Full Text] [Related]
32. Clinical character of pediatric head and neck rhabdomysarcomas: a 7-year retrospective study.
Zhang WL; Zhang Y; Huang DS; Guo F; Han T; Hong L; Hu HM; Zhi T
Asian Pac J Cancer Prev; 2013; 14(7):4089-93. PubMed ID: 23991958
[TBL] [Abstract][Full Text] [Related]
33. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
34. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
35. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
[TBL] [Abstract][Full Text] [Related]
36. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
37. Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables.
Bergamaschi L; Chiaravalli S; Livellara V; Sironi G; Puma N; Nigro O; Gattuso G; Luksch R; Terenziani M; Spreafico F; Meazza C; Podda M; Biassoni V; Schiavello E; Hovsepyan S; Morosi C; Vennarini S; Massimino M; Casanova M; Ferrari A
Pediatr Blood Cancer; 2023 Jan; 70(1):e30050. PubMed ID: 36215173
[TBL] [Abstract][Full Text] [Related]
38. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
39. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM
Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183
[TBL] [Abstract][Full Text] [Related]
40. Local Treatment of Children Suffering From Parameningeal Rhabdomyosarcoma: A Retrospective Single-Center Study From China.
Peng X; Xiong X; Li Y; Li C; Wang Z; Wu Y; Su M; Weng W; Huang K; Zhou D; Fang J
Cancer Control; 2024; 31():10732748241240655. PubMed ID: 38514935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
